老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ascendis Pharma A/S

223.21
-3.7900-1.67%
盘后：223.210.00000.00%19:30 EDT
成交量：59.22万
成交额：1.33亿
市值：147.74亿
市盈率：17.58
高：228.91
开：225.99
低：222.21
收：227.00
52周最高：282.15
52周最低：186.05
股本：6,618.99万
流通股本：6,553.95万
量比：0.69
换手率：0.90%
股息：- -
股息率：- -
每股收益(TTM):12.70
每股收益(LYR):-4.4176
净资产收益率：118.78%
总资产收益率：9.58%
市净率：9.18
市盈率(LYR):-50.53

数据加载中...

总览公司新闻资讯公告
2020/12/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/10/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/09/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/05/22

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/08

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/04/03

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/01

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/05

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多